Riskpilot← Back to searchSign inGet full accessASTMA OG ALLERGISENTERET AS
ASActiveOrg 993420972Vestre Strandgate 32, 4612 Kristiansand SGeneral medical practice activities · NACE 8621Est. 20098 employees
Revenue 2024
NOK 9,9M
+13% vs 2023
EBITDA margin
30.1%
+85% vs 2023
Equity ratio
5.2%
Financial strength
Net profit 2024
NOK 2,1M
+91% vs 2023
| Revenue | NOK 9,9M | +13% |
| EBITDA | NOK 3M | +85% |
| Net profit | NOK 2,1M | +91% |
| Total assets | NOK 3,8M | +31% |
| Equity | NOK 201K | -33% |
| Employees | 8 | — |
Legal name
ASTMA OG ALLERGISENTERET AS
Org number
993420972
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. januar 2009
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Legevirksomhet med alt dette tilhører, samt å delta i andre virksomheter i samme eller lignende bransjer.
Address
Vestre Strandgate 32, 4612 Kristiansand S
Phone
+4738095705
Email
jostein.rostrup@aoas.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 609 | 8 478 | 8 487 | 8 804 | 9 923 |
| Staff expenses | −2 661 | −4 761 | −4 831 | −5 059 | −4 715 |
| EBITDA | 3 856 | 2 205 | 1 693 | 1 620 | 2 989 |
| Depreciation & amort. | −168 | −211 | −268 | −242 | −293 |
| EBIT | 3 688 | 1 994 | 1 425 | 1 378 | 2 696 |
| Net financials | 8 | 5 | −0 | 2 | 4 |
| Profit before tax | 3 697 | 1 999 | 1 425 | 1 380 | 2 700 |
| Tax | 814 | 426 | 325 | 280 | 595 |
| Net profit | 2 883 | 1 573 | 1 100 | 1 100 | 2 105 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 332 | 3 558 | 3 036 | 2 932 | 3 842 |
| Equity | 701 | 700 | 700 | 300 | 201 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 631 | 2 857 | 2 336 | 2 632 | 3 641 |
| Total debt | 4 631 | 2 857 | 2 336 | 2 632 | 3 641 |
EBITDA margin
30.1%
This company
15.8%
Market median
+91% vs market
20202024
Equity ratio
5.2%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
1049.7%
This company
18.4%
Market median
+5605% vs market
20202024
Net profit margin
21.2%
This company
8.1%
Market median
+162% vs market
20202024
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20202024
Debt / equity
18.16×
This company
0.62×
Market median
-2829% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
WW Deputy Member | Deputy Member | 2009 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Chairman | 2021 – 2023 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Emkatt As
ASTMA OG ALLERGISENTERET AS Board members of ASTMA OG ALLERGISENTERET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wigdis Watnedalen | Deputy Member | 0 companies |
| Dan Lærum | Chairman | 0 companies |
| Jostein Rostrup | Chairman | 0 companies |
| Vibeke Hagerup Lærum | Board of Directors | 0 companies |